Sign In
Get Clay Free →

Suggestions

    Barry Boland

    Lecturer in Pharmacology at University College Cork, Ireland (UCC)

    Barry Boland is a dedicated researcher focusing on developing disease-modifying drugs for age-related neurodegenerative diseases like Alzheimer's and Parkinson's diseases by targeting the early pathogenesis causative factors.

    His expertise lies in understanding the excessive accumulation of intracellular metabolites within the endosomal-autophagic-lysosomal (EAL) system that contributes to neurodegenerative stress.

    Barry actively collaborates with clinicians on translational research to identify biomarkers of this pathology in patient biosamples, aiming to pave the way for future diagnostic tools and therapeutic interventions.

    His specific research projects include developing biomarker assays and therapies for EAL dysfunction, exploring the connection between storage diseases and Alzheimer's/Parkinson's, and studying the impact of age-related osmotic stress on neuronal catabolic flux.

    Barry Boland holds a Ph.D. in Physiology from Trinity College, Dublin, and a B.Sc. in Pharmacology from University College Dublin.

    Throughout his career, he has been involved with prestigious organizations, such as being a Lecturer in Pharmacology at University College Cork (UCC), a Scientific Project Manager for BIOMARKAPD (Research Fellow) at Trinity College Dublin, a HRB Post-Doctoral Research Fellow at University College Dublin, and a Wellcome Trust International Research Fellow at the University of Oxford and the Nathan S. Kline Institute of Psychiatric Research at New York University.

    B
    Add to my network

    Location

    Ireland